Literature DB >> 7620283

Inhibitory capacity of human serum on induced microsomal lipoperoxidation.

J J Hicks1, R Medina-Navarro.   

Abstract

The capacity of human serum for inhibiting in vitro the membrane lipoperoxidation induced by a controlled system (ADP/NADPH + H+/Fe3+) was demonstrated. A concentration of 8 nmol of malondialdehyde was produced in 20 min in rat liver microsomes (1.5 mg of protein) after exposure to an induced lipoperoxidation mixture. Addition of 100 microliters (13.89 mg of protein) of human serum decreased malondialdehyde production nearly 50%. An increase of 25.97% of the inhibitory capacity of serum was obtained by the in vitro addition of 10 microliters/ml of vitamin E. Ten volunteers were supplemented with 400 mg of vitamin E and 1 g of vitamin C/daily for 2 weeks. Their serum inhibitory capacity increased in 12% (p < 0.05). The serum inhibitory capacity for microsomal lipoperoxidation is described herein, and we propose its utilization as an index to determine the individual nonspecific antioxidative defenses against free radical injury and lipoperoxidation in relation to exposure to air pollutants, tobacco smoke, and several acute and chronic diseases, including the hypoxia-reperfusion phenomena.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620283

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  3 in total

1.  Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis.

Authors:  M P Cruz-Domínguez; D H Montes-Cortes; I M Olivares-Corichi; O Vera-Lastra; G Medina; L J Jara
Journal:  Rheumatol Int       Date:  2013-03-02       Impact factor: 2.631

2.  Protein conjugated with aldehydes derived from lipid peroxidation as an independent parameter of the carbonyl stress in the kidney damage.

Authors:  Rafael Medina-Navarro; Renato Nieto-Aguilar; Cleto Alvares-Aguilar
Journal:  Lipids Health Dis       Date:  2011-11-07       Impact factor: 3.876

3.  Oxidant/antioxidant state in tissue of prymary and recurrent pterygium.

Authors:  Alexandre Kormanovski; Fidelina Parra; Adriana Jarillo-Luna; Eleazar Lara-Padilla; Judith Pacheco-Yépez; Rafael Campos-Rodriguez
Journal:  BMC Ophthalmol       Date:  2014-11-27       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.